| Status | Study |
| Recruiting |
Study Name: A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria Condition: Type 2 Diabetes Mellitus Date: 2017-04-13 Interventions: Drug: metformin oral |
| Recruiting |
Study Name: Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China Condition: Type 2 Diabetes Mellitus Date: 2017-02-22 Interventions: Drug: No Treatment No treatment |
| Not yet recruiting |
Study Name: GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes Condition: Type2 Diabetes Kidney Diseases Date: 2017-01-20 Interventions: Drug: Exenatide Extended Release for Inj Susp 2 MG |
| Enrolling by invitation |
Study Name: Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes Condition: Chronic Kidney Disease Diabetes Mellitus Date: 2017-01-04 Interventions: Behavioral: MyFitnessPal For a |
| Not yet recruiting |
Study Name: Sodium Lowering and Urinary Protein Reduction Trial Condition: Chronic Kidney Disease Albuminuria Date: 2016-10-25 Interventions: Behavioral: Low Sodium Diet Once randomized to the Intervention program, study participants will be grou |
| Recruiting |
Study Name: Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes Condition: Type 2 Diabetes Diabetic Nephropathy Date: 2016-09-09 Interventions: Drug: Dapagliflozine 10 mg once daily tablet treatment |
| Recruiting |
Study Name: Does Micro-albuminuria is a Predictive Factor for Cognitive Impairment in Persons Living With HIV (PLHIV) Who Achieve cART-sustained Immunovirological Control ? Condition: HIV Date: 2016-07-26 Interventions: Behavioral: Cognitive function tests |
| Completed |
Study Name: Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria Condition: Hypertension Date: 2016-06-17 Interventions: Drug: CS-3150 CS-3150 1.25 to 2.5, 5mg, orally |
| Not yet recruiting |
Study Name: Microalbuminuria Predicting CIAKI After CAG Condition: Contrast-induced Acute Kidney Injury Microalbuminuria Date: 2016-06-13 Interventions: Other: microalbuminuria |
| Recruiting |
Study Name: CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea Condition: Diabetic Nephropathy Sleep Apnea Date: 2016-05-31 Interventions: Device: Continuous positive airway pressure |